Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022



Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.

generic oncology drug market

IMARC’s latest study “Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report.

Key Questions Answered in This Report:

  • How has the generic drug market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic drug industry?
  • What are the various stages in the value chain of the generic drug industry?
  • What are the key driving factors and challenges in the generic drug industry?
  • How has the generic oncology drug market performed so far and how will it perform in the coming years?
  • What is the structure of the generic drug industry and who are the key players?
  • What is the degree of competition in the generic drug industry?
  • What are the profit margins in the generic drug industry?
  • What are the key requirements for setting up generic drug manufacturing plant?
  • How are generic drug manufactured?
  • What are the various unit operations involved in generic drug plant?
  • What is the total size of land required for setting up generic drug plant?
  • What are the machinery requirements for setting up generic drug plant?
  • What are the raw material requirements for setting up generic drug plant?
  • What are the packaging requirements for generic drug?
  • What are the transportation requirements for generic drug?
  • What are the utility requirements for setting up generic drug plant?
  • What are the manpower requirements for setting up generic drug plant?
  • What are the infrastructure costs for setting up generic drug plant?
  • What are the capital costs for setting up generic drug plant?
  • What are the operating costs for setting up generic drug plant?
  • What will be the income and expenditures for generic drug plant?
  • What is the time required to break-even?

1 Preface
2 Research Methodology
3 Executive Summary
4 Introduction

    4.1 Overview    
    4.2 Key Industry Trends
5 Global Generic Drug Market
    5.1 Market Overview
    5.2 Market Performance
    5.3 Market Breakup by Region
    5.4 Market Forecast
    5.5 SWOT Analysis
        5.5.1 Strengths
        5.5.2 Weaknesses
        5.5.3 Opportunities
        5.5.4 Threats
    5.6 Value Chain Analysis
    5.7 Porter’s Five Forces Analysis
        5.7.1 Overview
        5.7.2 Bargaining Power of Buyers
        5.7.3 Bargaining Power of Suppliers
        5.7.4 Degree of Competition
        5.7.5 Threat of New Entrants
        5.7.6 Threat of Substitutes
        5.7.7 Regulations in the Generics Industry
    5.9 Key Market Drivers and Success Factors
6 Global Generic Oncology Drug Market
    6.1 Market Overview
    6.2 Market Trends
    6.3 Top Generic Oncology Drugs
    6.4 Market Forecast
7 Global Generic Drug Market: Performance of Key Regions
    7.1 USA
    7.2 China
    7.3 Brazil
    7.4 Germany
    7.5 France
8 Global Generic Drug Market: Competitive Landscape
    8.1 Competitive Structure
    8.2 Market Breakup by Key Players
    8.3 Key Player Profiles
        8.3.1 Teva Pharmaceuticals 
        8.3.2 Novartis - Sandoz
        8.3.3 Mylan
        8.3.4 Fresenius
        8.3.5 Hospira
9 Generic Oncology Drug Manufacturing Process
    9.1 Product Overview
    9.2 Detailed Process Flow (Tablets)
    9.3 Detailed Process Flow (Injectable)
    9.4 Various Types of Unit Operations Involved
    9.5 Mass Balance and Raw Material Requirements
10 Project Details, Requirements and Costs Involved
    10.1 Land Requirements and Expenditures
    10.2 Construction Requirements and Expenditures
    10.3 Plant Machinery
    10.4 Machinery Pictures
    10.5 Raw Material Requirements and Expenditures
    10.6 Packaging Requirements and Expenditures
    10.7 Transportation Requirements and Expenditures
    10.8 Utility Requirements and Expenditures
    10.9 Manpower Requirements and Expenditures
    10.10 Other Capital Investments
11 Loans and Financial Assistance
12 Project Economics
    12.1 Capital Cost of the Project
    12.2 Techno-Economic Parameters
    12.3 Product Pricing and Margins Across Various Levels of the Supply Chain
    12.4 Taxation and Depreciation
    12.5 Income Projections
    12.6 Expenditure Projections
    12.7 Financial Analysis
    12.8 Profit Analysis

 
List of Figures

Figure 1: Global: Generic Oncology Drug Industry Overview
Figure 2: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2010 – 2016
Figure 3: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 – 2022
Figure 4: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2016
Figure 5: Global: Generic Oncology Drug Industry: SWOT Analysis
Figure 6: Global: Generic Oncology Drug Industry: Value Chain Analysis
Figure 7: Global: Generic Oncology Drug Industry: Porter’s Five Forces Analysis
Figure 8: Global: Generic Oncology Drug Industry Overview
Figure 9: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2010 – 2016
Figure 10: Global: Generic Oncology Drug Market: Top Generic Oncology Drug
Figure 11: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 – 2022
Figure 12: USA: Generic Drug Market (in Million US$), 2009, 2016 & 2022
Figure 13: China: Generic Drug Market (in Million US$), 2009, 2016 & 2022
Figure 14: Brazil: Generic Drug Market (in Million US$), 2009, 2016 & 2022
Figure 15: Germany: Generic Drug Market (in Million US$), 2009, 2016 & 2022
Figure 16: France: Generic Drug Market (in Million US$), 2009, 2016 & 2022
Figure 17: Generic Oncology Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 18: Generic Oncology Drug Manufacturing: Production Cost Breakup (in %)
Figure 19: Generic Oncology Drug Manufacturing Plant: Detailed Process Flow
Figure 20: Generic Oncology Drug Manufacturing Process: Conversion Rate of Feedstocks
Figure 21: Generic Oncology Drug Manufacturing Plant: Proposed Plant Layout
Figure 22: Generic Oncology Drug Manufacturing Plant: Breakup of Capital Costs (in %)
 
List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2016 and 2022
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2017-2022
Table 3: Global: Generic Oncology Drug Market: Key Industry Highlights, 2016 and 2022
Table 4: Generic Oncology Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 5: Generic Oncology Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 6: Generic Oncology Drug Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 7: Generic Oncology Drug Manufacturing Plant: Raw Material Requirements
Table 8: Generic Oncology Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 9: Generic Oncology Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 10: Details of Financial Assistance Offered by Financial Institutions
Table 11: Generic Oncology Drug Manufacturing Plant: Capital Costs (in US$)
Table 12: Generic Oncology Drug Manufacturing Plant: Techno-Economic Parameters
Table 13: Generic Oncology Drug Manufacturing Plant: Taxation and Depreciation
Table 14: Generic Oncology Drug Manufacturing Plant: Income Projections (in US$)
Table 15: Generic Oncology Drug Manufacturing Plant: Expenditure Projections (in US$)
Table 16: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 17: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Table 18: Generic Oncology Drug Manufacturing Plant: Profit and Loss Account


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Artificial organs are engineered devices that are implanted in a human body in order to replace a natural organ or perform a specific function. They are composed of the plastic that is seeded with stem cells from the transplant recipient, hence the body’s immune system does not reject the artifici...


Biopreservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The latest report by IMARC Group, titled “Biopreservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the market has witnessed a healthy growth over the past few years, reaching a value of about US$ 2.5 Billion in 2016.


GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GCC generic drugs industry in any manner.


US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s new report titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the US generic injectables market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016.


Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global generic injectables market reached a value of more than US$ 23 Billion in 2016, exhibiting a CAGR of around 9% during 2009-...